The influence of antibodies to TNF-α and IL-1β on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats

British Journal of Pharmacology

Volumn 125, Issue 7, 1998, Pages 1543-1550

  Gardiner, S M ^a   Kemp, P A ^a   March, J E ^a   Woolley, J ^b   Bennett, T ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Therapeutic Antibodies Inc   (United Kingdom)

Author keywords

Antibodies; Interleukin 1 ; Lipopolysaccharide; Tumour necrosis factor

Indexed keywords

INTERLEUKIN 1 ANTIBODY; LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEART RATE; HEMODYNAMICS; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; TACHYCARDIA; VASOCONSTRICTION; VASODILATATION;

EID: 0031764399     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702250     Document Type: Article

References (44)

1. BATAILLARD, A. & SASSARD, J. (1994). Cardiovascular effects of human recombinant interleukin-1β in conscious rats. Am. J. Physiol., 266, R1148-R1153.
2. BAUDRY, N., RASETTI, C. & VICAUT, E. (1996). Differences between cytokine effects in the microcirculation of the rat. Am. J. Physiol., 271, H1186-H1192.
3. BAUE, A.E.(1996). MOF/MODS, SIRS: an update. Shock, 6,S1-S5.
4. BAZZONI, F. & BEUTLER, B. (1996). The tumor necrosis factor ligand and receptor families. New Eng. J. Med., 334, 1717-1725.
5. BERNARD, G.R. (1995). Sepsis Trials: intersection of investigation, regulation, funding and practice. Am. J. Respir. Crit. Care Med., 152, 4-10.
6. BLACKWELL, T.S. & CHRISTMAN, J.W. (1996). Sepsis and cytokines: current status. Br. J. Anaesth., 77, 110-117.
7. CAVAILLON, J.-M., MUNOZ, C., FITTING, C., MISSET B. & CARLET, J. (1992). Circulating cytokines: the tip of the iceberg? Circ. Shock. 38, 145-152.
8. CORDER, R., CARRIER, M., KHAN, N., KLEMM, P. & VANE, J.R. (1995). Cytokine regulation of endothelin-1 release from bovine aortic endothelial cells. J. Cardiovasc. Pharmacol., 26 (Suppl. 3), S56-S58.
9. DEITCH, E.A. (1998). Animal models of sepsis and shock: a review and lessons learned. Shock, 9, 1-11.
10. DINARELLO, C.A. (1994). Interleukin-1. Adv. Pharmacol., 25, 21-51.
11. EDER, J (1997). Tumour necrosis factor a and interleukin 1 signalling: do MAPKK kinases connect it all? Trends Pharmacol. Sci., 18, 319-322.
12. FINKELMAN, F.D., MADDEN, K.B., MORRIS, S.C., HOLMES, J.M., BOIANI, N., KATONA, I.M. & MALISZEWSKI, C.R. (1993). Anticytokine antibodies as carrier proteins: prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J. Immunol., 151, 1235-1244.
13. FOULKES, R. & SHAW, S. (1992). The cardiodepressant and vasodepressant effects of tumour necrosis factor in rat isolated atria] and aortic tissues. Br. J. Pharmacol., 106, 942-947.
14. GALLEY, H.F. & WEBSTER, N.R. (1996). The immuno-inflammatory cascade. Br. J. Anaesth., 77, 11-16.
15. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1995). Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br. J. Pharmacol., 116, 2005-2016.
16. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1996a). Effects of dexamethasone and SB 209670 on the regional haemodynamic responses to lipopolysaccharide in conscious rats. Br. J. Pharmacol., 118, 141-149.
17. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1996b). Influence of aminoguanidine and the endothelin antagonist SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats. Br. J. Pharmacol., 118, 1822-1828.
18. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1996c). Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats. Br. J. Pharmacol., 119, 1619-1627.
19. GARDINER, S.M., KEMP, P.A., MARCH, J.E., WOOLLEY, J. & BENNETT, T. (1998a). Effects of sheep polyclonal antibodies to human TNF-:α and IL-1β on cardiovascular responses to the cytokines in conscious rats. Br. J. Pharmacol., 123, 308P.
20. GARDINER, S.M., KEMP, P.A., MARCH, J.E., WOOLLEY, J. & BENNETT, T. (1998b). Effect of sheep antibodies to human TNF-α and IL-1β on cardiovascular responses to lipopolysaccharide (LPS) in conscious rats. Br. J. Pharmacol., 123, 309P.
21. GARDINER, S.M., KEMP, P.A., WOOLEEY, J. & BENNETT, T. (1997a). Regional vasodilator responses to lipopolysaccharide compared to tumour necrosis factor-α plus interleukin-1β in conscious rats, J. Vasc. Re., 34 (Suppl. 1), 17.
22. GARDINER, S.M., KEMP, P.A., WOOLLEY, J. & BENNETT, T. (1997b). Hypotensive and vasodilator responses to human recombinant interleukin-1β in conscious rats. J. Vnsc. Res., 34 (Suppl. 1), 18.
23. GOTO, K., HAMA, H. & KASUYA, Y. (1996). Molecular pharmacology and pathophysiological significance of endothelin. Jpn. J. Pharmacl., 72, 261-290.
24. GULICK, T., CHUNG, M.K., PIEPER, S.J., LANGE, L.G. & SCHREINER, G.F. (1989). Interleukin 1 and tumor necrosis factor inhibit cardiac myocytc β-adrenergic responsiveness. Proc. Natl. Acad. Sci. U.S.A., 86, 6753-6757.
25. LIN, M.T., LIU, H.H. & YANG, Y.L. (1997). Involvement of interleukin-1 receptor mechanisms in development of arterial hypotension in rat heatstroke. Am. J. Physiol., 273, H2072-H2077.
26. MORIMOTO, K., MORIMOTO, A., NAKAMORI, T., TAN, N., MINAGAWA, T. & MURAKAMI, N. (1992). Cardiovascular responses induced in free-moving rats by immune cytokines. J. Physiol., 448, 307-320.
27. NEILSON, I.R., NEILSON, K.A., YUNIS, E.J. & ROWE, M.I. (1989). Failure of tumor necrosis factor to produce hypotensive shock in the absence of endotoxin. Surgery. 106, 439-443.
28. NIIJIMA, A., HORI, T., AOU, S. & OOMURA, Y. (1991). The effects of interleukin-1β on the activity of adrenal, splenic and renal sympathetic nerves in the rat. J. Anton. Nerv. Syst., 36, 183-192.
29. PARILLO, JE (1993). Pathogenetic mechanisms of septic shock. New Eng. J. Med., 328, 1471-1477.
30. ROBERT, R., CHAPELAIN, B., JEAN, T. & NELIAT, G. (1992). Interleukin-1 impairs both vascular contraction and relaxation in rabbit isolated aorta. Biochem, Biophys. Res. Commun., 182, 733-739.
31. ROTHWELL, N.J., LUHESHI, G. & TOULMOND, S. (1996). Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology. Pharmacol. Ther., 69, 85-95.
32. RUETTEN, H., SMITH, D., THIEMERMANN, C. & VANE, J.R. (1996). Effects of polyclonal antibodies against TNFα or IL-1β on the multiple organ failure syndrome elicited by endoloxin in the anaesthetised rat. Br. J. Pharmacol., 119, 19P.
33. SZABO, C., THIEMERMANN, C. & VANE, J.R. (1993). Inhibition of the production of nitric oxide and vasodilator prostaglandins attenuates the cardiovascular response to bacterial endotoxin in adrenalectomized rats. Proc. Roy. Soc. Lond. B., 253, 233-238.
34. TAKAHASHI, K., ANO, A., ONO, A., SHIMOSAWA, T., OGATA, E. & FUJITA, T. (1992). Tumor necrosis factor-α induces vascular hyporesponsiveness in Sprague-Dawley rats. Life Sci., 50, 1437-1444.
35. THEODORSSON-NORHEIM, E. (1987). Friedman and Quade tests: BASIC computer program to perform non-parametric two-way analysis of variance and multiple comparisons on ranks of several related samples. Comput. Biol. Med., 17, 85-99.
36. TOMLINSON, A., GARDINER, S.M., WILLIS, D., ALI, J., KEMP, P.A., WILLOUGHBY, D.A. & BENNETT, T. (1998). Temporal and spatial expression of the inducible isoforms of cyclooxygenase. nitric oxide synthase and heme oxygenase in tissues from rats infused with LPS in the conscious state. Br. J. Pharmacol., 123, 178P.
37. TRACEY, K.J. & CERAMI, A. (1994). Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med., 45, 491-503.
38. TURNER, C.R. ESSER, K.M., WHEELDON, E.B., SLIVJAK, M. & SMITH, E.F. (1989). Cardiovascular and pulmonary effects of human recombinant tumor necrosis factor in the conscious rat. Cire. Shock, 28, 369-384.
39. WALLER, J., GARDINER, S.M., JOSE, J. & BENNETT, T. (1995). Lack of effect of TNF antibodies on the cardiovascular sequelae of lipopolysaccharide infusion in conscious rats. Br. J. Pharmacol., 116, 2487-2495.
40. WANG, P. BA, Z.F. & CHAUDRY, I.H. (1994). Administration of tumor necrosis faelor-α in vivo depresses endothelium-dependent relaxation. Am. J. Physioi., 266, H2535-H2541.
41. WATANABE, T., TAN, N., SAIKI, Y., MAKISUMI, T. & NAKAMURA, S. (1996). Possible involvement of glucocorticoids in the modulation of interleukin-1-induced cardiovascular responses in rats. J. Physiol., 491, 231-239.
42. XIE, J., JOSEPH, K.O., BAGBY, G.J., GILES, T.D. & GREENBERG, S.S. (1997). Dissociation of TNF-α from endotoxin-induced nitric oxide and acute-phase hypotension. Am. J. Physioi., 273, H164-H174.
43. YAMAMOTO, N., SAKAI, F., YAMAZAKI, H., SATO, N., NAKAHARA, K. & OKUHARA, M. (1997). FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-α, ameliorates endotoxin-induced shock. Eur. J. Pharmacol., 327, 169-175.
44. YOSHIZUMI, M., KURIHARA, H., MORITA, T., YAMASHITA, T., OHHASHI, Y., SUGIYAMA, T., TAKAKU, F., YANAGISAWA, M., MASAKI, T. & YAZAKI, Y. (1990). Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem. Biophys. Res. Commun., 166, 324-329.